Skip to main content

EB05-04-2020 EDESA - A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 and SOC versus Placebo and SOC in Adult Hospitalized Patients with COVID-19

NCT04401475

EDESA - A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 and SOC versus Placebo and SOC in Adult Hospitalized Patients with COVID-19

Associated Conditions

COVID-19

Principal Investigator

Daniel Layish

Sponsor

Edesa Biotech Research

The purpose of this study is to evaluate the clinical efficacy and safety of EB05 and Standard of Care vs. Standard of Care alone in adult hospitalized patients with COVID-19. This is a Phase II/III study conducted in two stages: Stage 1 (Phase II) and Stage 2 (Phase III). Furthermore, some patients will be part of the Main Study and others will be part of the sub-study depending on their initial disease severity.

This study is currently enrolling.